The Journal of Practical Medicine ›› 2023, Vol. 39 ›› Issue (16): 2122-2129.doi: 10.3969/j.issn.1006-5725.2023.16.019
• Medical Examination and Clinical Diagnosis • Previous Articles Next Articles
Yubo HUANG,Yuqi ZHOU,Wenzheng ZHENG,Jiaxin ZHU,Hailing YANG,Wenbin WU,Tiantuo. ZHANG()
Received:
2023-07-14
Online:
2023-08-25
Published:
2023-09-26
Contact:
Tiantuo. ZHANG
E-mail:zhtituli@163.com
CLC Number:
Yubo HUANG,Yuqi ZHOU,Wenzheng ZHENG,Jiaxin ZHU,Hailing YANG,Wenbin WU,Tiantuo. ZHANG. Analysis of efflux pump and outer membrane protein of multi⁃drug resistant Acinetobacter baumannii[J]. The Journal of Practical Medicine, 2023, 39(16): 2122-2129.
Tab.1
Primers for fluorescent quantitative PCR"
基因 | 引物 | 序列 (5′-3′) |
---|---|---|
rpoB | rpoB_rtRev | ATGCCGCCTGAAAAAGTAAC |
rpoB_rtFor | TCCGCACGTAAAGTAGGAAC | |
adeB | adeB_rtFor | CTTGCATTTACGTGTGGTGT |
adeB_rtRev | GCTTTTCTACTGCACCCAAA | |
adeJ | adeJ_rtFor | GGTCATTAATATCTTTGGC |
adeJ_rtRev | GGTACGAATACCGCTGTCA | |
adeG | adeG_rtFor | GTGTAGTGCCACTGGTTACT |
adeG_rtRev | ATGTGGGCTAGCTAACGGC | |
craA | craA_rtFor | TTCATTGCTTGCGCCTTT |
craA_rtRev | CCAGTGCCATGAAACATAATCA | |
abeM | abeM_rtFor | AGGGACGTATTATGGCGAAA |
abeM_rtRev | CTGCTGTGCTTAGACCAATTTTT | |
amvA | amvA_rtFor | GCAGAGAAATTTTGCACTTGG |
amvA_rtRev | CGACTAATGGACCAAAAGCTG | |
omp25 | omp25_rtFor | CGAACGTGAAATCGACAACA |
omp25_rtRev | CGTAACCTTTAACACCTAGAGCAAG | |
omp33-36 | omp33-36_rtFor | CAAGTGTTGCTAACCAATTCGCT |
omp33-36_rtRev | GTTTTCTTGACCGAATGCACC | |
carO | carO_rtFor | TGTTCATGACAGCTATGCATTCGATA |
carO_rtRev | CCCAATGCTAAACCTACATATGGGT |
Tab.3
Relative expression of efflux pump genes and OMP genes in different antibiotic groups [median (M)]"
抗生素 | 组别 | adeB | adeJ | adeG | craA | abeM | amvA | omp25 | omp33-36 | carO |
---|---|---|---|---|---|---|---|---|---|---|
AMK | NS组(n = 190) | 10.164 | 0.826 | 0.326 | 0.630 | 0.042 | 0.318 | 3.294 | 2.589 | 5.880 |
S组(n = 23) | 4.280 | 0.685 | 0.145 | 0.533 | 0.051 | 0.288 | 5.826 | 2.454 | 9.580 | |
IPM | NS组(n = 173) | 10.759 | 0.798 | 0.325 | 0.659 | 0.041 | 0.324 | 3.488 | 2.799 | 6.681 |
S组(n = 40) | 4.280 | 0.806 | 0.230 | 0.524 | 0.047 | 0.237 | 3.371 | 2.278 | 4.149 | |
CFP | NS组(n = 207) | 8.892 | 0.798 | 0.306 | 0.634 | 0.043 | 0.322 | 3.488 | 2.594 | 6.364 |
S组(n = 6) | 2.568 | 0.798 | 0.057 | 0.331 | 0.023 | 0.205 | 2.163 | 2.350 | 6.099 | |
FEP | NS组(n = 207) | 9.399 | 0.798 | 0.286 | 0.625 | 0.041 | 0.313 | 3.464 | 2.594 | 6.233 |
S组(n = 6) | 0.162 | 0.882 | 0.217 | 0.619 | 0.118 | 0.349 | 4.793 | 2.038 | 11.306 | |
TZP | NS组(n = 209) | 8.892 | 0.798 | 0.286 | 0.625 | 0.041 | 0.313 | 3.488 | 2.594 | 6.298 |
S组(n = 4) | 1.071 | 0.751 | 0.210 | 0.760 | 0.302 | 0.424 | 3.232 | 1.991 | 13.033 | |
CAZ | NS组(n = 207) | 9.399 | 0.804 | 0.286 | 0.634 | 0.041 | 0.314 | 3.440 | 2.594 | 6.169 |
S组(n = 6) | 0.162 | 0.610 | 0.245 | 0.528 | 0.118 | 0.278 | 6.619 | 2.038 | 13.945 | |
SXT | NS组(n = 196) | 8.831 | 0.815 | 0.295 | 0.630 | 0.040 | 0.314 | 3.452 | 2.594 | 6.331 |
S组(n = 17) | 5.667 | 0.483 | 0.268 | 0.522 | 0.060 | 0.346 | 6.309 | 2.297 | 6.364 | |
CIP | NS组(n = 207) | 9.399 | 0.798 | 0.286 | 0.625 | 0.041 | 0.313 | 3.464 | 2.594 | 6.233 |
S组(n = 6) | 0.162 | 0.882 | 0.217 | 0.619 | 0.118 | 0.349 | 4.793 | 2.038 | 11.306 | |
SCF | NS组(n = 201) | 10.393 | 0.798 | 0.306 | 0.634 | 0.041 | 0.314 | 3.464 | 2.630 | 6.233 |
S组(n = 12) | 1.182 | 0.882 | 0.181 | 0.534 | 0.096 | 0.290 | 3.560 | 2.321 | 10.524 | |
CN | NS组(n = 204) | 9.667 | 0.801 | 0.296 | 0.630 | 0.041 | 0.077 | 3.452 | 2.594 | 6.201 |
S组(n = 9) | 0.227 | 0.785 | 0.260 | 0.533 | 0.077 | 0.346 | 5.143 | 2.594 | 10.091 |
Tab.4
Distribution of adeB gene (RE≥1) in different antibiotic groups"
抗生素 | 分组 | RE < 1 | RE ≥ 1 | χ 2 值 | P值 |
---|---|---|---|---|---|
AMK | NS组 | 9(4.74) | 181(95.30) | 9.658 | 0.002 |
S组 | 5(21.70) | 18(78.30) | |||
IPM | NS组 | 7(4.00) | 166(96.00) | 9.576 | 0.002 |
S组 | 7(17.50) | 33(82.50) | |||
CFP | NS组 | 140(67.60) | 67(32.40) | 1.024 | 0.311 |
S组 | 5(83.30) | 1(16.70) | |||
FEP | NS组 | 10(4.80) | 197(95.20) | 36.308 | < 0.001 |
S组 | 4(66.70) | 2(33.30) | |||
TZP | NS组 | 12(5.70) | 197(94.30) | 12.52 | < 0.001 |
S组 | 2(50.00) | 2(50.00) | |||
CAZ | NS组 | 10(4.80) | 197(95.20) | 36.308 | < 0.001 |
S组 | 4(66.70) | 2(33.30) | |||
SXT | NS组 | 11(5.60) | 185(94.40) | 3.690 | 0.055 |
S组 | 3(17.60) | 14(82.40) | |||
CIP | NS组 | 10(4.80) | 197(95.20) | 36.308 | < 0.001 |
S组 | 4(66.70) | 2(33.30) | |||
SCF | NS组 | 8(4.00) | 193(96.00) | 39.054 | < 0.001 |
S组 | 6(50.00) | 6(50.00) | |||
CN | NS组 | 9(4.40) | 195(95.60) | 36.716 | < 0.001 |
S组 | 5(55.60) | 4(44.40) |
1 | YOON E J, CHABANE Y N, GOUSSARD S, et al. Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii[J]. mBio, 2015,6(2): e00309-15. |
2 | ANTUNES L C, VISCA P, TOWNER K J. Acinetobacter baumannii: evolution of a global pathogen[J]. Pathog Dis, 2014,71(3): 292-301. |
3 | MARAGAKIS L L, PERL T M. Antimicrobial Resistance: Acinetobacter baumannii: Epidemiology, Antimicrobial Resistance, and Treatment Options[J]. Clin Infect Dis, 2008,46(8): 1254-1263. |
4 | TACCONELLI E, CARRARA E, SAVOLDI A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis[J]. Lancet Infect Dis, 2018,18(3): 318-327. |
5 | ZHANG Z, MORGAN C E, BONOMO R A, et al. Cryo-EM Determination of Eravacycline-Bound Structures of the Ribosome and the Multidrug Efflux Pump AdeJ of Acinetobacter baumannii[J]. mBio, 2021,12(3): e103121. |
6 | ABDI S N, GHOTASLOU R, GANBAROV K, et al. Acinetobacter baumannii Efflux Pumps and Antibiotic Resistance[J]. Infect Drug Resist, 2020,13: 423-434. |
7 | MUNOZ-PRICE L S, WEINSTEIN R A. Acinetobacter infection[J]. N Engl J Med, 2008,358(12): 1271-1281. |
8 | HIGGINS P G, WISPLINGHOFF H, KRUT O, et al. A PCR-based method to differentiate between Acinetobacter baumannii and Acinetobacter genomic species 13TU[J]. Clin Microbiol Infect, 2007,13(12): 1199-1201. |
9 | HIGGINS P G, LEHMANN M, WISPLINGHOFF H, et al. gyrB Multiplex PCR To Differentiate between Acinetobacter calcoaceticus and Acinetobacter Genomic Species 3[J]. J Clin Microbiol, 2010,48(12): 4592-4594. |
10 | CLSI. Performance Standards for Antimicrobial Susceptibility Testing, Twenty-Second Informational Supplement [S]. PA: Wayne, 2012. |
11 | COYNE S, GUIGON G, COURVALIN P, et al. Screening and Quantification of the Expression of Antibiotic Resistance Genes in Acinetobacter baumannii with a Microarray[J]. Antimicrob Agents Chemother, 2010,54(1): 333-340. |
12 | COYNE S, ROSENFELD N, LAMBERT T, et al. Overexpression of Resistance-Nodulation-Cell Division Pump AdeFGH Confers Multidrug Resistance inAcinetobacter baumannii[J]. Antimicrob Agents Chemother, 2010,54(10): 4389-4393. |
13 | RUMBO C, GATO E, LÓPEZ M, et al. Contribution of Efflux Pumps, Porins, and β-Lactamases to Multidrug Resistance in Clinical Isolates of Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2013,57(11): 5247-5257. |
14 | YOON E, COURVALIN P, GRILLOT-COURVALIN C. RND-Type Efflux Pumps in Multidrug-Resistant Clinical Isolates of Acinetobacter baumannii: Major Role for AdeABC Overexpression and AdeRS Mutations[J]. Antimicrob Agents Chemother, 2013,57(7): 2989-2995. |
15 | HARDING C M, HENNON S W, FELDMAN M F. Uncovering the mechanisms of Acinetobacter baumannii virulence[J]. Nat Rev Microbiol, 2018,16(2): 91-102. |
16 | GIAMMANCO A, CALA C, FASCIANA T, et al. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial[J]. mSphere, 2017,2(1): e00310-16. |
17 | PEREZ S, INNES G K, WALTERS M S, et al. Increase in Hospital-Acquired Carbapenem-Resistant Acinetobacter baumannii Infection and Colonization in an Acute Care Hospital During a Surge in COVID-19 Admissions-New Jersey, February-July 2020[J]. MMWR Morb Mortal Wkly Rep, 2020,69(48): 1827-1831. |
18 | 胡付品, 朱德妹, 汪复, 等. 2014年CHINET中国细菌耐药性监测[J]. 中国感染与化疗杂志, 2015, 15(5): 401-410. |
19 | 胡付品, 郭燕, 朱德妹, 等. 2021年CHINET中国细菌耐药监测[J]. 中国感染与化疗杂志, 2022,22(5): 521-530. |
20 | VERMA P, TIWARI M, TIWARI V. Efflux pumps in multidrug-resistant Acinetobacter baumannii: Current status and challenges in the discovery of efflux pumps inhibitors[J]. Microb Pathog, 2021,152: 104766. |
21 | NOWAK J, SCHNEIDERS T, SEIFERT H, et al. The Asp20-to-Asn Substitution in the Response Regulator AdeR Leads to Enhanced Efflux Activity of AdeB in Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2016,60(2): 1085-1090. |
22 | DAMIER-PIOLLE L, MAGNET S, BRÉMONT S, et al. AdeIJK, a Resistance-Nodulation-Cell Division Pump Effluxing Multiple Antibiotics in Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2008,52(2): 557-562. |
23 | POURNARAS S, MARKOGIANNAKIS A, IKONOMIDIS A, et al. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit[J]. J Antimicrob Chemother, 2006,57(3): 557-561. |
24 | WIECZOREK P, SACHA P, CZABAN S, et al. Distribution of AdeABC efflux system genes in genotypically diverse strains of clinical Acinetobacter baumannii[J]. Diagn Microbiol Infect Dise, 2013,77(2): 106-109. |
25 | COYNE S, COURVALIN P, PÉRICHON B. Efflux-Mediated Antibiotic Resistance in Acinetobacter spp[J]. Antimicrob Agents Chemother, 2011,55(3): 947-953. |
26 | LIN L, LING B, LI X. Distribution of the multidrug efflux pump genes, adeABC, adeDE and adeIJK, and class 1 integron genes in multiple-antimicrobial-resistant clinical isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus complex[J]. Int J Antimicrob Agents, 2009,33(1): 27-32. |
27 | SEN B, JOSHI S G. Studies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistance[J]. J Appl Microbiol, 2016,120(3): 619-629. |
28 | ALMASAUDI S B. Acinetobacter spp. as nosocomial pathogens: Epidemiology and resistance features[J]. Saudi J Biol Sci, 2018,25(3): 586-596. |
29 | HOU P F, CHEN X Y, YAN G F, et al. Study of the Correlation of Imipenem Resistance with Efflux Pumps AdeABC, AdeIJK, AdeDE and AbeM in Clinical Isolates of Acinetobacter baumannii[J]. Chemotherapy, 2012,58(2): 152-158. |
30 | UPPALAPATI S R, SETT A, PATHANIA R. The Outer Membrane Proteins OmpA, CarO, and OprD of Acinetobacter baumannii Confer a Two-Pronged Defense in Facilitating Its Success as a Potent Human Pathogen[J]. Front Microbiol, 2020,11: 589234. |
31 | BOU G, CERVERO G, DOMINGUEZ M A, et al. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strain with a carbapenem-hydrolyzing enzyme: high-level carbapenem resistance in A. baumannii is not due solely to the presence of beta-lactamases[J]. J Clin Microbiol, 2000,38(9): 3299-3305. |
32 | DEL M T M, BECEIRO A, PEREZ A, et al. Cloning and functional analysis of the gene encoding the 33- to 36-kilodalton outer membrane protein associated with carbapenem resistance in Acinetobacter baumannii[J]. Antimicrob Agents Chemother, 2005,49(12): 5172-5175. |
33 | MUSSI M A, LIMANSKY A S, VIALE A M. Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins[J]. Antimicrob Agents Chemother, 2005,49(4): 1432-1440. |
34 | FERNANDEZ-CUENCA F, SMANI Y, GOMEZ-SANCHEZ M C, et al. Attenuated virulence of a slow-growing pandrug-resistant Acinetobacter baumannii is associated with decreased expression of genes encoding the porins CarO and OprD-like[J]. Int J Antimicrob Agents, 2011,38(6): 548-549. |
[1] | Shu CHEN,Jinglei ZHANG,Kang RONG,Nan ZHANG,Weiyi SUN. Research progress of exosomes in distant metastasis and drug resistance of gastric cancer [J]. The Journal of Practical Medicine, 2024, 40(6): 870-876. |
[2] | Nenhan WANG,Yanfeng ZHAO,Lili TIAN,Shuangshuang CHEN,Hao CHEN,Yixuan REN,Chuanyou LI,Xiaowei. DAI. Clinical application of fluorescence polymerase chain reaction probe melting curve technique in detecting isoniazid drug⁃resistance of Mycobacterium tuberculosis in sputum samples [J]. The Journal of Practical Medicine, 2023, 39(20): 2664-2670. |
[3] | Xiaorong LIU,Yue HE,Yan CHEN,Zefeng XIN,Xuwen DENG,Huifeng ZHONG,Yunsheng. CHEN. Construction of chronic myeloid leukemia K562 cell line with overexpression of human TCRP1 gene based on lentivirus vector and its biological function detection [J]. The Journal of Practical Medicine, 2023, 39(19): 2456-2460. |
[4] | ZHANG Ling, JIN Chenghao, KONG Chun⁃ fang. . Mechanism of glucocorticoid resistance in multiple myeloma [J]. The Journal of Practical Medicine, 2023, 39(11): 1457-1460. |
[5] |
WANG Nan, DENG Li, NIU Qun, WU Ling, LEI Jie, XIE Bei, YANG Yu, LI Hua, LIU Zhihui, MENG Fanrong. .
Analysis of Pyrazinamide resistance characteristics of Mycobacterium tuberculosis clinical isolates in south⁃ ern China [J]. The Journal of Practical Medicine, 2022, 38(6): 696-700. |
[6] |
LIU Miao, WANG Ce, MU Hong..
Pathogenic bacteria distribution and drug resistance analysis after liver transplantation in children [J]. The Journal of Practical Medicine, 2022, 38(22): 2861-2867. |
[7] |
WANG Xuechun, LIANG Ail⁃ ing, LIU Yongjun..
Research progress of PDK4 and drug resistance in non⁃small cell lung cancer [J]. The Journal of Practical Medicine, 2022, 38(22): 2880-2884. |
[8] |
XU Qingqing, CHEN Wentao, JIANG Yinbo, LAN Yinyuan, PAN Yuying, ZENG Li⁃ hong, YANG Jianjiang, XUE Yaohua, ZHENG Heping..
Preparation and identification of peptide polyclonal antibodies against major outer membrane protein of Chlamydia trachomatis [J]. The Journal of Practical Medicine, 2022, 38(11): 1333-1338. |
[9] |
LIN Beibei, HUANG Xiaoqiao, YAO Meicun, FENG Weixun, FENG Xiangxing, ZHU Shaoqin, ZHU Weixing, GAN Guoxing, YANG Xiaocui..
Early Banxia Xiexin decoction and late Xiangsha Liujunzi decoction combined with chinese medicine Diyu and triple therapy for treatment of refractory Helicobacter pylori infection in stages [J]. The Journal of Practical Medicine, 2021, 37(6): 811-815. |
[10] |
YAN Feifei, LI Hongwu..
MicroRNA ⁃140⁃5p affects the sensitivity of colorectal cancer cells to oxaliplatin by regulating autophagy [J]. The Journal of Practical Medicine, 2021, 37(23): 2984-2988. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||